Wai Chun Bio-Technology Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'25
Jun'24
Jun'23
Jun'22
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-8.00
-78.00
-5.00
2.00
1.00
9.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-12.00
38.00
26.00
-37.00
-20.00
-7.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-1.00
49.00
45.00
0.00
-5.00
11.00
Cash Flow from Investing Activities
-26.00
-40.00
-28.00
-16.00
-12.00
-12.00
Cash Flow from Financing Activities
31.00
-13.00
-17.00
17.00
16.00
1.00
Net Cash Inflow / Outflow
4.00
-4.00
-1.00
2.00
0.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
1.00
1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Wai Chun Bio-Technology Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-8.931
-40.4805813837451
32.00
77.94%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-12.861
15.2745454932023
-27.00
-184.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-1.016
-10.8053748143991
9.00
90.60%
Cash Flow from Investing Activities
-26.014
-27.2465451621362
1.00
4.52%
Cash Flow from Financing Activities
31.335
9.94016418808055
22.00
215.24%
Net Cash Inflow / Outflow
4.397
-28.443528284261
32.00
115.46%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.092
-0.331772495806353
0.00
127.73%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'25
YoY Growth in year ended Jun 2025 is -102.06% vs 8.80% in Jun 2024
Jun'25
Jun'24
Change(%)
Cash Flow from Operating Activities
-1.02
49.41
-102.06%






